CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE
申请人:BioMarin Pharmaceutical Inc.
公开号:US20190322676A1
公开(公告)日:2019-10-24
Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with the enzyme ceramide galactosyltransferase (CGT), such as, for example, lysosomal storage diseases. Examples of lysosomal storage diseases include, for example, Krabbe disease and Metachromatic Leukodystrophy.
US9580444B2
申请人:——
公开号:US9580444B2
公开(公告)日:2017-02-28
[EN] POLYCYCLIC PYRAZOLINONE DERIVATIVE AND HERBICIDE COMPRISING SAME AS EFFECTIVE COMPONENT THEREOF<br/>[FR] DÉRIVÉ DE PYRAZOLINONE POLYCYCLIQUE ET HERBICIDE LE COMPRENANT À TITRE DE PRINCIPE ACTIF
POLYCYCLIC PYRAZOLINONE DERIVATIVE AND HERBICIDE COMPRISING SAME AS EFFECTIVE COMPONENT THEREOF
申请人:SAGAMI CHEMICAL RESEARCH INSTITUTE
公开号:US20160024110A1
公开(公告)日:2016-01-28
Provided are a polycyclic pyrazolinone derivative indicated by general formula (1) (in the formula, R
1
, X
1
, X
2
, X
3
, and Y indicate the definitions provided in the Specification) and a herbicide comprising same as effective component thereof.